Found: 10
Select item for more details and to access through your institution.
Modeling, instrumentation, automation, and optimization of water resource recovery facilities (2019) DIRECT.
- Published in:
- Water Environment Research (10614303), 2020, v. 92, n. 10, p. 1499, doi. 10.1002/wer.1394
- By:
- Publication type:
- Article
P1‐058: EFFECTS OF THE EPIGENETIC BET‐INHIBITOR SMALL MOLECULE APABETALONE ON COGNITION IN PATIENTS WITH DIABETES AND CARDIOVASCULAR DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P255, doi. 10.1016/j.jalz.2019.06.083
- By:
- Publication type:
- Article
P2‐037: APABETALONE (AN EPIGENETIC BET‐INHIBITOR SMALL MOLECULE) AND EFFECTS ON COGNITION IN DIABETES PATIENTS WITH CARDIOVASCULAR DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P680, doi. 10.1016/j.jalz.2018.06.721
- By:
- Publication type:
- Article
Telemedicine in the emergency department in the era of COVID‐19: front‐line experiences from 2 institutions.
- Published in:
- Journal of the American College of Emergency Physicians Open, 2020, v. 1, n. 6, p. 1630, doi. 10.1002/emp2.12204
- By:
- Publication type:
- Article
BET Protein Inhibition for Pulmonary Arterial Hypertension: A Pilot Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- letter
Benchmarking Case Studies: Journeys Into Continuous Improvement.
- Published in:
- Journal: American Water Works Association, 2020, v. 112, n. 1, p. 75, doi. 10.1002/awwa.1435
- By:
- Publication type:
- Article
Pharmacokinetics of Levodopa/Carbidopa Delivered From Gastric-Retentive Extended-Release Formulations in Patients With Parkinson’s Disease.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Pharmacokinetics of Levodopa/Carbidopa Delivered From Gastric-Retentive Extended-Release Formulations in Patients With Parkinson’s Disease.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, n. 7, p. 1069, doi. 10.1177/0091270011409232
- By:
- Publication type:
- Article
Apabetalone Mediated Epigenetic Modulation is Associated with Favorable Kidney Function and Alkaline Phosphatase Profile in Patients with Chronic Kidney Disease.
- Published in:
- Kidney & Blood Pressure Research, 2018, v. 43, n. 2, p. 449, doi. 10.1159/000488257
- By:
- Publication type:
- Article
Favorable cognitive effects of the BET protein inhibitor apabetalone in patients 70 and older.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057846
- By:
- Publication type:
- Article